The Alzheimer's Innovation Award will help advance particularly critical components of Mucke's ongoing drug discovery program to identify and
optimize small molecule compounds that potently and safely reduce tau levels in the brain.
Not exact matches
Such projects involve developing and
optimizing assays for automation, screening a large
compound library, and characterizing each
small -
molecule probe.
Currently, Everon is
optimizing several lead
compounds:
small molecules and biologics that have already demonstrated a rejuvenation effect in aging animals, as measured by a lowered mouse FI (similar FI has recently been accepted by FDA as a measure of aging in the ongoing Metformin human trial).